USFDA Issues 8 Observations for Sun Pharma Halol Plant Operations
Sun Pharma, India's largest drug manufacturer, announced on June 14, 2025, that the US Food and Drug Administration (USFDA) conducted an inspection at its Halol manufacturing facility in Gujarat from June 2-13, 2025. Following the inspection, the USFDA issued a Form 483 with 8 observations, highlighting areas of concern related to good manufacturing practices (GMP).
According to the USFDA, a Form 483 is issued to a company when an inspection identifies potential violations of the Food, Drug, and Cosmetic Act or related regulations. While the specific details of the 8 observations remain undisclosed, Sun Pharma has stated it is committed to addressing the issues raised and ensuring compliance with global regulatory standards.
This is not the first time the Halol facility has been under scrutiny. Observations in past inspections have led to significant operational and regulatory challenges for the company. The latest findings could potentially impact product approvals from this site, which plays a critical role in Sun Pharma's global supply chain.
The company plans to respond to the USFDA promptly and implement corrective measures to resolve all noted concerns. These developments underscore the importance of strict regulatory compliance in maintaining market credibility.
You May Interested In
SS-31 Cosmetic peptides, discounted price improving cognitive impairment factory supply
$8E+1/UNIT FOB
2026-09-09
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
FDA Lifts Administrative Stay, Restoring Red No. 3 Ban Timeline for Food and Ingested Drugs
-
EAEU Initiates Review of Anti-Dumping Measures on Chinese Titanium Dioxide, Suspends Duties During Investigation
-
China NMPA Issues Priority Review Pathway for Four Categories of Chemical Active Pharmaceutical Ingredients, Effective August 1, 2026
-
U.S. FDA Opens New Safety Review of RSV Treatments for Infants
-
The FDA Officially Blesses AI for Liver Drug Development
-
EU Biocidal Data Protection Extension Raises the Stakes for Chemical Market Entry
-
WACKER’s 2025 Loss Reaches €805 Million as the PACE Cost-Cutting Plan Becomes the Key Variable for 2026
-
Your Plant Has the Data. Your AI Cannot Reach It. Here Is Why That Is the Core Problem in Chemical Manufacturing.
-
FDA Fee Updates Raise the Cost of Entering the U.S. Generic Drug Chain
-
U.S. Imposes 12.5% Additional Tariff! Nutritional Ingredients Including Creatine, Taurine, and Glucosamine Included in New Section 301 Tariff List
Recommend Reading
-
![FDA Dye Pledges Push Natural Colors Into the Mainstream]()
FDA Dye Pledges Push Natural Colors Into the Mainstream
-
![China’s New Food-Contact Standards Take Effect, Resetting Compliance for Coatings and Silicone Rubber]()
China’s New Food-Contact Standards Take Effect, Resetting Compliance for Coatings and Silicone Rubber
-
![U.S. Formally Publishes India PFA Trade Cases, Raising New Barriers for Fluoropolymer Supply]()
U.S. Formally Publishes India PFA Trade Cases, Raising New Barriers for Fluoropolymer Supply
-
![Pakistan Launches Successive Anti-dumping Investigations against Chinese Products, Involving Soda Ash, Ibuprofen and Other Raw Materials]()
Pakistan Launches Successive Anti-dumping Investigations against Chinese Products, Involving Soda Ash, Ibuprofen and Other Raw Materials
-
![关于全面排查下架易制毒及易制爆产品信息的公告 Announcement on the Comprehensive Review and Removal of Product Information Related to Precursor and Explosive Precursor Chemicals]()
关于全面排查下架易制毒及易制爆产品信息的公告 Announcement on the Comprehensive Review and Removal of Product Information Related to Precursor and Explosive Precursor Chemicals
-
![Cost support increases, DOP prices rise then fall this week in China]()
Cost support increases, DOP prices rise then fall this week in China
-
![This week, the TDI market in China rose slightly (11.3-11.7)]()
This week, the TDI market in China rose slightly (11.3-11.7)
-
![This Week's Styrene Market Continues to Show Weakness (11.3-11.7)]()
This Week's Styrene Market Continues to Show Weakness (11.3-11.7)
-
![This Week's Pure Benzene Market Prices Show Slight Fluctuations (Nov. 3–Nov. 8)]()
This Week's Pure Benzene Market Prices Show Slight Fluctuations (Nov. 3–Nov. 8)
-
![Supply Contraction Drives Dichloromethane Prices Up in China]()
Supply Contraction Drives Dichloromethane Prices Up in China
